This information was published on 2025-10-23T00:11:06 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2550040 (IR 1864372) |
| (220) |
22 May 2025
|
| (511) (510) |
Class 5
pharmaceutical preparations; medicine; drugs for medical use; drugs for medical purposes; pharmaceutical drugs; pharmaceutical and medical preparations; pharmaceutical preparations and substances; medicines; pharmaceuticals; hormones for medical use; pharmaceutical products for use by humans; pharmaceutical pills; hormones for medical purposes; therapeutic drugs and agents; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the endocrine system; pharmaceutical preparations containing hormones for humans; all the aforementioned being for human use; none of the aforementioned containing or being derived from organisms of the genus Anthia or Anthias; all of the aforementioned relating to the treatment of women’s health; none of the aforementioned being cosmetic or body care preparations Class 44 providing medical treatment; healthcare; provision of medical treatment; medical services; medical treatment services; medical and health care services; medical treatment services provided by clinics and hospitals; providing healthcare services; prescription of medicines; medical, medicinal and pharmaceutical consultancy; medical and healthcare services; all the aforementioned being in relation to humans |
| (540) | ANTHIA Life Sciences |
| (550) | Word |
| (730) |
Anthia Life Sciences Pty Ltd
ACN/ABN 99679715863 |
| (750) |
Argyll Law
|
Find out more about publications on the About page.